The European Medicines Agency (EMA) drugs advisory panel has recommended the oral SGLT1/2 inhibitor as an adjunct to insulin for patients with type 1 diabetes who can’t maintain blood glucose ...
A report from The Lancet Diabetes & Endocrinology Commission has proposed new criteria for defining and diagnosing obesity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback